Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback